We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
SWM
1351
Spire Wealth Management
Virginia
$4.28M -$877K -5,898 -17%
WKSWA
1352
White Knight Strategic Wealth Advisors
New Jersey
$4.28M +$5.95K +40 +0.1%
NSAM
1353
North Star Asset Management
Wisconsin
$4.27M -$112K -750 -3%
AMG
1354
Advisors Management Group
Wisconsin
$4.26M -$2.23K -15 -0.1%
SIM
1355
Studio Investment Management
Illinois
$4.26M +$55.5K +373 +1%
MIM
1356
Marco Investment Management
Georgia
$4.25M +$26.9K +181 +0.6%
CCA
1357
Checchi Capital Advisers
California
$4.25M -$354K -2,378 -8%
FCP
1358
Fidelis Capital Partners
Florida
$4.23M +$366K +2,460 +10%
GFA
1359
Gifford Fong Associates
California
$4.22M
AF
1360
Alerus Financial
North Dakota
$4.21M +$3.73M +25,070 +667%
CT
1361
Clearstead Trust
Maine
$4.21M -$82.4K -554 -2%
DBIA
1362
Dumont & Blake Investment Advisors
New Jersey
$4.21M +$1.97M +13,269 +85%
RMAM
1363
Raab & Moskowitz Asset Management
New Jersey
$4.21M -$92.4K -621 -2%
PAMG
1364
Patton Albertson Miller Group
Tennessee
$4.21M -$44.8K -301 -1%
MCCP
1365
Mission Creek Capital Partners
California
$4.21M +$11.3K +76 +0.3%
FMTC
1366
Farmers & Merchants Trust Company
California
$4.21M +$263K +1,768 +7%
HH
1367
Hilltop Holdings
Texas
$4.21M +$265K +1,785 +7%
PCMI
1368
Paradigm Capital Management Inc
New York
$4.19M
PAM
1369
Pegasus Asset Management
New York
$4.19M +$72.6K +488 +2%
HCM
1370
Hall Capital Management
Rhode Island
$4.19M -$55.3K -372 -1%
WIA
1371
World Investment Advisors
California
$4.18M +$3.45M +23,186 +430%
NERM
1372
New England Research & Management
Illinois
$4.17M -$187K -1,260 -4%
MYLI
1373
Meiji Yasuda Life Insurance
Japan
$4.17M -$136K -917 -3%
WA
1374
WBH Advisory
Maryland
$4.14M -$314K -2,114 -7%
ACM
1375
Altrius Capital Management
North Carolina
$4.12M +$477K +3,210 +13%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.